Gabather ABOSTO:GABA -2.44% PB Ratio is 6.40 as of Jul. 11, 2026, which is 801% above its 10-year median of 0.71. The stock has 2 warning signs investors should review. Among 919 Drug Manufacturers companies, Gabather AB ranks worse than 88.14% on this metric.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-11), Gabather AB's share price is kr0.032. Gabather AB's Book Value per Share for the quarter that ended in Mar. 2026 was kr0.01. Hence, Gabather AB's PB Ratio of today is 6.40.
Warning Sign:
Gabather AB stock PB Ratio (=7.16) is close to 10-year high of 7.16.
The historical rank and industry rank for Gabather AB's PB Ratio or its related term are showing as below:
OSTO:GABA'
s PB Ratio Range Over the Past 10 Years
Min: 0.01 Med: 0.71 Max: 7.16
Current: 6.4
During the past 12 years, Gabather AB's highest PB Ratio was 7.16. The lowest was 0.01. And the median was 0.71.
OSTO:GABA's PB Ratio is ranked worse than 88.14% of 919
companies
in the Drug Manufacturers industry
Industry Median: 1.9
vs OSTO:GABA: 6.40
During the past 12 months, Gabather AB's average Book Value Per Share Growth Rate was 150.00% per year.
During the past 3 years, the average Book Value Per Share Growth Rate was -68.70% per year.
During the past 12 years, the highest 3-Year average Book Value Per Share Growth Rate of Gabather AB was 26.40% per year. The lowest was -75.30% per year. And the median was -34.50% per year.
The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.
Be Aware
Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.
Gabather AB PB Ratio Related Terms
Gabather AB PB Ratio Historical Data
* Premium members only.
The historical data trend for Gabather AB's PB Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Gabather AB's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gabather AB PB Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Gabather AB's PB Ratio distribution charts can be found below:
* The bar in red indicates where Gabather AB's PB Ratio falls into.
The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.
Gabather AB's PB Ratio for today is calculated as follows:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
It can also be calculated from the numbers for the whole company:
A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.
Gabather AB (OSTO:GABA) has a PB Ratio of 6.40 as of Jul. 11, 2026. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Gabather AB and its competitors. This is 801% above median its historical median of 0.71. Over the past decade, Gabather AB's PB Ratio has ranged from 0.01 to 7.16. According to the industry distribution chart, Gabather AB ranks #810 out of 919 companies in the Drug Manufacturers industry, placing it in the top 88.1%.
Is Gabather AB's PB Ratio too high?
Gabather AB's current PB Ratio of 6.40 is 801% above median its 10-year median of 0.71. Over the past 10 years, this metric has ranged from a low of 0.01 to a high of 7.16. The Drug Manufacturers industry median PB Ratio is 1.90. Gabather AB's value of 6.40 is 236.8% above this industry median. Based on the distribution chart, Gabather AB ranks #810 out of 919 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Gabather AB's PB Ratio compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Gabather AB ranks #810 out of 919 companies for PB Ratio. This places Gabather AB in the lower half of its industry. The industry median PB Ratio is 1.90. Gabather AB's value of 6.40 is 236.8% above this benchmark. Historically, Gabather AB's own PB Ratio has ranged from 0.01 to 7.16 over the past decade. While the company's 10-year median is 0.71 vs. the industry median of 1.90, Gabather AB has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good PB Ratio for a Drug Manufacturers company?
The median PB Ratio among Drug Manufacturers companies is 1.90, based on 919 companies in the industry. Companies in the top quartile (top 25%) have a PB Ratio significantly above this median, while those in the bottom quartile fall well below. However, PB Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Gabather AB's current PB Ratio of 6.40 is 236.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high PB Ratio mean?
A high PB Ratio can signal that a stock is expensive relative to its fundamentals. Price-to-Book ratio is the ratio of share price to a company's book value per share. View historical data on Gabather AB and its competitors. For the Drug Manufacturers industry, the median PB Ratio is 1.90 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Gabather AB's current PB Ratio is 6.40, which is 801% above median its own 10-year median of 0.71. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gabather AB stock overvalued right now?
Gabather AB (OSTO:GABA) has a current PB Ratio of 6.40. The current PB Ratio is 6.40, which is 801% above median its 10-year median of 0.71 and 236.8% above the Drug Manufacturers industry median of 1.90. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is PB Ratio calculated?
PB Ratio is calculated from a company's financial statements. For Gabather AB (OSTO:GABA), the current PB Ratio is 6.40 as of Jul. 11, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
OSTO:GABA has been successfully added to your 